AngioDynamics, Inc. (ANGO)
15.98
-0.15
(-0.93%)
USD |
NASDAQ |
Sep 01, 10:28
AngioDynamics Total Long Term Debt (Quarterly) : 9.66M for May 31, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | 9.66M |
| February 28, 2026 | 10.08M |
| November 30, 2025 | 10.48M |
| August 31, 2025 | 7.825M |
| May 31, 2025 | 2.106M |
| February 28, 2025 | 2.571M |
| November 30, 2024 | 3.03M |
| August 31, 2024 | 3.49M |
| May 31, 2024 | 3.939M |
| February 29, 2024 | 2.322M |
| November 30, 2023 | 2.568M |
| August 31, 2023 | 2.942M |
| May 31, 2023 | 53.13M |
| February 28, 2023 | 52.86M |
| November 30, 2022 | 53.29M |
| August 31, 2022 | 53.81M |
| May 31, 2022 | 29.70M |
| February 28, 2022 | 30.38M |
| November 30, 2021 | 31.01M |
| August 31, 2021 | 31.67M |
| May 31, 2021 | 27.32M |
| February 28, 2021 | 37.94M |
| November 30, 2020 | 47.64M |
| August 31, 2020 | 48.18M |
| May 31, 2020 | 48.34M |
| Date | Value |
|---|---|
| February 29, 2020 | 22.06M |
| November 30, 2019 | 3.191M |
| August 31, 2019 | 3.489M |
| May 31, 2019 | 131.91M |
| February 28, 2019 | 133.09M |
| November 30, 2018 | 144.27M |
| August 31, 2018 | 90.44M |
| May 31, 2018 | 91.62M |
| February 28, 2018 | 92.80M |
| November 30, 2017 | 93.97M |
| August 31, 2017 | 95.15M |
| May 31, 2017 | 96.32M |
| February 28, 2017 | 97.52M |
| November 30, 2016 | 115.16M |
| August 31, 2016 | 118.15M |
| May 31, 2016 | 120.54M |
| February 29, 2016 | 126.41M |
| November 30, 2015 | 133.91M |
| August 31, 2015 | 136.41M |
| May 31, 2015 | 137.66M |
| February 28, 2015 | 148.91M |
| November 30, 2014 | 155.16M |
| August 31, 2014 | 141.41M |
| May 31, 2014 | 142.66M |
| February 28, 2014 | 138.91M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Boston Scientific Corp. | 12.62B |
| Penumbra, Inc. | 198.31M |
| Abbott Laboratories | 32.61B |
| Alphatec Holdings, Inc. | 597.42M |
| AtriCure, Inc. | 72.53M |